Greenwich LifeSciences (GLSI) is scheduled to report Q1 earnings on June 26, 2026. Analysts estimate EPS of $-0.35 and quarterly revenue of N/A.
In the most recent quarter (Q4), Greenwich LifeSciences reported EPS of $-0.58, missing estimates of $-0.32 by 0.81%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Greenwich LifeSciences has averaged an EPS surprise of 0.31% and a revenue surprise of 0.00%.
Analyze the earnings history of Greenwich LifeSciences using advanced sorting and filters.
The chart below shows Greenwich LifeSciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Greenwich LifeSciences's reported revenue compared to analyst estimates over recent quarters.
Greenwich LifeSciences (GLSI) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on June 1, 2026 for Q4.
The Actual EPS was $-0.58, which missed the estimate of $-0.32.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-06-01 | $-0.58 | $-0.32 | -81.3 % |
| Q3 | 2025-11-14 | $-0.30 | $-0.32 | 6.25 % |
| Q2 | 2025-08-14 | $-0.30 | $-0.23 | -30.4 % |
| Q3 | 2024-11-14 | $-0.20 | $-0.21 | 4.76 % |